/
/
/

Medico Remedies Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021
₹69 Cr₹57 Cr₹59 Cr₹53 Cr₹38 Cr₹41 Cr₹39 Cr₹39 Cr₹31 Cr₹41 Cr₹30 Cr₹42 Cr₹31 Cr₹28 Cr₹39 Cr₹40 Cr₹33 Cr₹32 Cr₹30 Cr₹30 Cr₹29 Cr
₹1 Cr₹3 Cr₹68 L₹2 Cr₹66 L₹29 L₹1 Cr₹68 L₹29 L₹58 L₹27 L₹96 L₹31 L₹4 L₹86 L₹2 Cr₹2 Cr₹74 L₹23 L₹80 L₹26 L
₹71 Cr₹60 Cr₹59 Cr₹54 Cr₹39 Cr₹42 Cr₹41 Cr₹40 Cr₹31 Cr₹42 Cr₹30 Cr₹43 Cr₹32 Cr₹28 Cr₹40 Cr₹42 Cr₹35 Cr₹33 Cr₹30 Cr₹30 Cr₹29 Cr
₹67 Cr₹50 Cr₹55 Cr₹51 Cr₹36 Cr₹35 Cr₹37 Cr₹38 Cr₹29 Cr₹37 Cr₹28 Cr₹40 Cr₹30 Cr₹26 Cr₹36 Cr₹38 Cr₹34 Cr₹31 Cr₹29 Cr₹28 Cr₹29 Cr
₹4 Cr₹10 Cr₹5 Cr₹4 Cr₹3 Cr₹7 Cr₹5 Cr₹3 Cr₹3 Cr₹5 Cr₹3 Cr₹4 Cr₹3 Cr₹3 Cr₹4 Cr₹5 Cr₹1 Cr₹3 Cr₹2 Cr₹3 Cr₹87 L
₹41 L₹90 L₹39 L₹24 L₹28 L₹49 L₹28 L₹21 L₹18 L₹25 L₹22 L₹18 L₹17 L₹21 L₹20 L₹17 L₹17 L₹13 L₹20 L₹17 L₹16 L
₹3 Cr₹8 Cr₹4 Cr₹3 Cr₹2 Cr₹6 Cr₹3 Cr₹2 Cr₹2 Cr₹4 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹3 Cr₹4 Cr₹65 L₹2 Cr₹2 Cr₹2 Cr₹28 L
₹3 Cr₹6 Cr₹3 Cr₹3 Cr₹2 Cr₹4 Cr₹3 Cr₹2 Cr₹2 Cr₹3 Cr₹1 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹3 Cr₹36 L₹2 Cr₹1 Cr₹2 Cr₹14 L

Share Price Live Stats

Open (₹)22.20
Volume (₹)1.55 L
High (₹)22.45
Upper Circuit24.03
Low (₹)21.80
Lower Circuit19.67
Prev Close21.85
52W High (₹)56.88
Price22.05
52W Low (₹)20.47

Share Market Cap & Key Ratios Overview

M.Cap (₹)182.90 Cr
Div. Yield (%)0.00
PE Ratio13.24
Debt to Equity0.25
Price to Book3.59
Book Value9.10
EPS (TTM)1.66
Face Value2.00
ROE (%)19.02

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
MEDICONSE
LTP
1W Low
1W High
Market cap (₹)
1764+4 (0.23%)
1725.50
1778
4,19,620Cr
9030-310 (-3.32%)
8937.50
9431.50
2,39,714Cr
4584.1-72.8 (-1.56%)
4551.80
4682
1,74,741Cr
1140.2+22.7 (2.03%)
1107.30
1150.90
1,12,119Cr
2018.5-18.1 (-0.89%)
2007.80
2069.20
1,10,008Cr
1328+27 (2.08%)
1300.20
1336.40
1,06,061Cr
1218.8+21.8 (1.82%)
1196.90
1250.70
1,01,339Cr
2347.6-20.9 (-0.88%)
2317.50
2426.80
96,244Cr
1677.9-15.1 (-0.89%)
1647.10
1715
95,590Cr
1980.9+24.4 (1.25%)
1925.70
1990.90
89,391Cr
22.05-0.75 (-3.29%)
21.25
23.54
183Cr

Key Highlights of Medico Remedies Ltd’s P&L

In 2025-03-31, Medico Remedies Ltd reported total revenue of ₹150.94Cr, compared with ₹144.92Cr in 2024-03-31, reflecting Medico Remedies Ltd turnover.

Depreciation was ₹3.03Cr and finance costs were ₹1.16Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹13.5Cr in 2025-03-31 as compared to ₹11.33Cr in 2024-03-31.

Net Profit (PAT) was ₹10.09Cr in 2025-03-31 compared with ₹8.29Cr in 2024-03-31.

Earnings per share (EPS) were ₹1.22 in 2025-03-31, compared with ₹1 in 2024-03-31.